BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23862126)

  • 1. Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis.
    Kim JY; Jeong D; Ahn TS; Kim HJ; Park DS; Park SY; Bae SB; Lee S; Lee SS; Lee MS; Cho HD; Baek MJ
    Ann Coloproctol; 2013 Jun; 29(3):93-9. PubMed ID: 23862126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
    Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
    Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted protein acidic and rich in cysteine expression in human colorectal cancer predicts postoperative prognosis.
    Liu QZ; Gao XH; Chang WJ; Wang HT; Wang H; Cao GW; Fu CG
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1803-11. PubMed ID: 26044224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
    Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
    Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis.
    Guo W; Zhang M; Chen Y; Guo S
    J Cancer Res Ther; 2017; 13(5):833-836. PubMed ID: 29237913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
    Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
    Naito T; Yuge R; Kitadai Y; Takigawa H; Higashi Y; Kuwai T; Kuraoka K; Tanaka S; Chayama K
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
    Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
    J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of the γ2 chain of laminin-5 and secreted protein acidic and rich in cysteine in esophageal squamous cell carcinoma and their relation to prognosis.
    Xue LY; Zou SM; Zheng S; Liu XY; Wen P; Yuan YL; Lin DM; Lu N
    Chin J Cancer; 2011 Jan; 30(1):69-78. PubMed ID: 21192846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
    Byrling J; Sasor A; Nilsson J; Said Hilmersson K; Andersson R; Andersson B
    Scand J Gastroenterol; 2020 Jun; 55(6):725-731. PubMed ID: 32543919
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of SPARC expression in pancreatic cancer progression and patient survival.
    Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
    Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.
    Sangaletti S; Stoppacciaro A; Guiducci C; Torrisi MR; Colombo MP
    J Exp Med; 2003 Nov; 198(10):1475-85. PubMed ID: 14610043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis.
    Shi S; Ma HY; Han XY; Sang YZ; Yang MY; Zhang ZG
    Biomed Res Int; 2022; 2022():8600419. PubMed ID: 35211625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells.
    Drev D; Harpain F; Beer A; Stift A; Gruber ES; Klimpfinger M; Thalhammer S; Reti A; Kenner L; Bergmann M; Marian B
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31554208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Levels of SPARC are Associated with Tumor Progression and Poor Prognosis in Human Endometrial Carcinoma.
    Wang L; Wang W; Xu Y; Wang Q
    Onco Targets Ther; 2020; 13():11549-11569. PubMed ID: 33204109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
    Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
    J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.
    Kao SC; Kirschner MB; Cooper WA; Tran T; Burgers S; Wright C; Korse T; van den Broek D; Edelman J; Vallely M; McCaughan B; Pavlakis N; Clarke S; Molloy MP; van Zandwijk N; Reid G
    Br J Cancer; 2016 Mar; 114(5):524-31. PubMed ID: 26889976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.
    Clark CJ; Sage EH
    J Cell Biochem; 2008 Jun; 104(3):721-32. PubMed ID: 18253934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.
    Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ
    Breast J; 2010; 16(3):305-8. PubMed ID: 20210803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.